NASDAQ:BIOC
Delisted
Biocept Stock News
$0.435
+0 (+0%)
At Close: Jan 23, 2024
Biocept to present study showcasing its ultra-sensative Target Selector biopsy assay kits at a virtual medical conference this week
10:40am, Tuesday, 16'th Feb 2021
Biocept Inc (NASDAQ:BIOC) announced Tuesday that its Target Selector molecular assay kit detected mutations in up to 50% of tissue biopsy specimens from non-small cell lung cancer patients that were d
SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, will present data showing that its Target Selector™ molecular assa
Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Tuesday, 02'nd Feb 2021
SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable
Biocept to Present at H.C. Wainwright Virtual BioConnect Conference
08:05am, Monday, 04'th Jan 2021
SAN DIEGO, Jan. 4, 2021 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically
Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:29pm, Thursday, 31'st Dec 2020
SAN DIEGO, Dec. 31, 2020 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinicall
Biocept Enters into Laboratory Services Agreements with Two Southern California Regional Independent Physician Associations
08:05am, Wednesday, 30'th Dec 2020
SAN DIEGO, Dec. 30, 2020 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinicall
SAN DIEGO, Nov. 20, 2020 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinicall
Biocept, Inc. (BIOC) CEO Michael Nall on Q3 2020 Results - Earnings Call Transcript
05:56am, Friday, 13'th Nov 2020
Biocept, Inc. (BIOC) CEO Michael Nall on Q3 2020 Results - Earnings Call Transcript
Biocept Receives Hong Kong Patent Covering the Enhanced Detection of Rare Cells, including Cancer Cells
08:05am, Monday, 09'th Nov 2020
SAN DIEGO, Nov. 9, 2020 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically
SAN DIEGO, Nov. 5, 2020 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic tests, products and services designed to provide physicians with clinically
Biocept Provides Update on COVID-19 Testing with More than 80,000 Samples Received
08:05am, Thursday, 29'th Oct 2020
SAN DIEGO, Oct. 29, 2020 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic tests and services for physicians treating patients with cancer, announces
Analyzing Teleflex (NYSE:TFX) & Viatar CTC Solutions (NYSE:VRTT)
02:58am, Thursday, 22'nd Oct 2020
Teleflex (NYSE:TFX) and Viatar CTC Solutions (OTCMKTS:VRTT) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institu
Savran Technologies Inc. Rare Cell Detection Platform Contributes to Successful Clinical Trial for Detecting Breast Cancer Recurrence
12:00am, Thursday, 15'th Oct 2020
Savran Technologies Inc. Rare Cell Detection Platform Contributes To Successful Clinical Trial
Global Liquid Biopsy Market Analysis and Forecast, 2020-2030 & Implications of COVID-19 Pandemic on the Market - ResearchAndMarkets.com
12:00am, Wednesday, 14'th Oct 2020
The
Volume Buzz: Biocept, Inc. (NASDAQ:BIOC), Future FinTech Group Inc. (NASDAQ:FTFT) - Stocks Equity
12:23pm, Saturday, 10'th Oct 2020
Biocept, Inc. (NASDAQ:BIOC) with the stream of -4.98% also noticed, India Future FinTech Group Inc. (NASDAQ:FTFT) encountered a rapid change of -3.21% in the last hour of Friday’s trading session. �
